Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored

Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

    Lead investigator    
            Dr Daman Langguth        

        Clinical trial coordinator		
				Venita Bali			

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

Latest News

Going Gluten Free – Pratical Tips for Coeliac Disease Management

Living with coeliac disease requires significant lifestyle changes. At Wesley Research Institute, we understand how overwhelming this journey can feel, whether you are newly diagnosed or supporting a loved one. In this article, we’ll share practical, research-backed tips to help both coeliac patients and their support networks navigate this transition with confidence.

Research Advisory Board

We welcome Dr John Rivers, Professor Janet Hardy, Professor Jennifer Byrne, Professor John Prins, Professor Steven Lane, Professor Cathy Mihalopoulos and Professor Jill Francis to our newly established Research Advisory Board.

Pulmonary Hypertension team’s visit to Saudi Arabia

Wesley Research Institute researcher Dr John Feenstra and Clinical Trial Coordinator Bronwen Field, had the privilege of attending the 18th Annual Scientific Meeting of the Saudi Arabia Pulmonary Hypertension Society recently.

1 2 3 … 20 Next »

Rare Diseases

Testing treatments to improve symptoms of Myositis